ARCHIVES

FDA Approves Erbitux for Head & Neck Cancer.

This article is from The Cancer Letter archive.

Vol. 32 No. 08 | March 3, 2006

Download PDF Visit The Full Archive

Related Articles

As NCI Sets Deadline For B-06 Reanalysis, Fisher Lawyer Says Demand Is Illegal

February 3, 1995

Gene Vector Labs Seek Vector Producers

February 23, 1996

FCRF Contracts Recompetition Will Be Along Same Lines As in 1982 But for at Least Seven Years

July 5, 1985

Conference Bill Includes Funding For DOD For Breast, Prostate, Ovarian Cancer

October 4, 1996

Summit Tells Women To Get A Mammogram, Encourages Others, Too

September 29, 1989

Funding Opportunity: DOD Devotes $150 Million to Breast Cancer Research

August 5, 2011